<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Amryt Pharma PLC

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals
    Invest Now

    About Amryt Pharma PLC

    Amryt Pharma is a specialty pharmaceutical company focused on the developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases.

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      Start Engine
    • RAISED AMOUNT
      $22,053,300.00
    • PRE-MONEY EVAULATION
      $74,617,340.55
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Joseph Wiley
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrate...

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a Sa...

    Filing Type:    PU
    So-Young International Inc.

    So-Young International Inc.

    So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”) is ...

    So-Young International Inc. (NASDAQ: SY) (“So...

    Filing Type:    PU
    Bioclonetics Immunotherapeutics, Inc.

    Bioclonetics Immunotherapeutics, Inc.

    BioClonetics Immunotherapeutics is a biotechnology company with a proprietary meth...

    BioClonetics Immunotherapeutics is a biotechnol...

    Amount Raised:    $255,600
    Fundraising Status:    EC
    Filing Type:    CF
    Arbutus Biopharma Corporation

    Arbutus Biopharma Corporation

    Arbutus Biopharma is a publicly-traded (NASDAQ:ABUS) biopharmaceutical company ded...

    Arbutus Biopharma is a publicly-traded (NASDAQ:...

    Filing Type:    PU
    Adaptimmune Therapeutics PLC

    Adaptimmune Therapeutics PLC

    Adaptimmune is a leader in TCR T-cell therapy, focused on developing novel cancer ...

    Adaptimmune is a leader in TCR T-cell therapy, ...

    Filing Type:    PU
    Mesoblast Limited

    Mesoblast Limited

    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a world leader in developing allogene...

    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a ...

    Filing Type:    PU
    Alterola Biotech, Inc.

    Alterola Biotech, Inc.

    Alterola Biotech Inc. provides medicinal delivery systems, offering nutraceutrical...

    Alterola Biotech Inc. provides medicinal delive...

    Amarillo Biosciences

    Amarillo Biosciences

    Amarillo Biosciences, Inc. develops biologics for the treatment of human and anima...

    Amarillo Biosciences, Inc. develops biologics f...

    Filing Type:    PU
    H&G Science LLC

    H&G Science LLC

    H&G Science aims to facilitate the safe and effective treatment of diseases, takin...

    H&G Science aims to facilitate the safe and eff...

    Amount Raised:    $24,000.00
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.